The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexMale
Age18-60
SponsorBangrak STIs Center
About this trial
The objective of this research is to evaluate the efficacy and safety of doxycycline in MSM for preventing sexually transmitted infections (gonorrhea, chlamydia, and syphilis) in Thailand
Participation in this study will last approximately 12 weeks and will include 2-3 clinic visits, along with 10-11 follow-up phone contacts over a period of 11 weeks.
Eligibility criteria
Qualifiers
None
Disqualifiers
History of allergy to tetracycline-class antibiotics
Trial design
Treatments tested in this trial
- Doxycycline (200mg/day)
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Bangrak STIs Center
Lead sponsor
Mahidol University
Collaborator
Source ClinicalTrials.gov